Clinical Trial Update: Prevention of Cardiac and Vascular Events in Patients With NGT/IGT. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating prevention of cardiac and vascular events in patients with normal glucose tolerance or impaired glucose tolerance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Cardiovascular Disease | Phase 3 | Status: COMPLETED